Raw Deflazacort ntụ ntụ (14484-47-0) hplc ma98% | AASraw
AASraw na-emepụta NMN na NRC ntụ ntụ n'ọtụtụ!

Deflazacort ntụ ntụ (14484-47-0)

Rating: SKU: 14484-47-0. Category:

AASraw nwere njikọ na mmepụta site na gram ka usoro nchịkọta nke Deflazacort Powder (14484-47-0), n'okpuru usoro CGMP na sistemu njikwa njikwa achọpụtara.

AASRAW ntụ ntụ PDF Icon

Product Description

 

Deflazacort Powder (14484-47-0) vidiyo

 

 


 

Deflazacort ntụ ntụ (14484-47-0) Specification:

Ngwurugwu Chemical: Product Name: Deflazacort
Cas Mba: 14484-47-0
molekụla Formula: C25H31NO6
molekụla arọ: 441.51674
Standard: N'ụlọ
nchekwa: Akọrọ, ọchịchịrị na 0 - 4 C maka obere oge (ụbọchị ruo izu) ma ọ bụ -20 C maka ogologo oge (ọnwa ruo afọ).
Akwụkwọ (COA & HPLC wdg): dị

Deflazacort ntụ ntụ (14484-47-0) Daha:

Deflazacort (aha ahia Emflaza n'etiti ndị ọzọ) bụ glucocorticoid eji dịka ọgwụ mgbochi na immunosuppressant. Deflazacort bụ prodrug. Ikike ya dị 70Â – 90% nke prednisone.Ọ bụ otu ọgwụ ọgwụ akpọrọ corticosteroids. Mgbe ụfọdụ a na-akpọ ya naanị ọgwụ steroid. Deflazacort bụ ọgwụ prodrug na-adịghị arụ ọrụ nke a na-enweta metabolized ngwa ngwa na ọgwụ na-arụ ọrụ 21-desacetyldeflazacort.I na-eji ọgwụgwọ dịgasị iche iche. Examplesfọdụ ọmụmaatụ gụnyere ọrịa autoimmune (dịka ọmụmaatụ, systemic lupus erythematosus (SLE), autoimmune hepatitis, sarcoidosis), ọrịa nkwonkwo na akwara (dịka ọmụmaatụ, ọrịa ogbu na nkwonkwo), na allergies na ashma.

 

Ntughari:

  • 1: McDonald CM, Sajeev G, Yao Z, McDonnell E, Elfring G, Souza M, Peltz SW, Darras BT, Shieh PB, Cox DA, Landry J, Signorovitch J; ACT DMD Study Group na Tadalafil DMD Study Group. Deflazacort vs prednisone treatment for Duchenne musical dystrophy: meta-analysis of health development rates in na nso nso multicenter ọnwụnwa. Olu akwara. 2019 Ọkt 10. doi: 10.1002 / mus.26736. [Epub n'ihu mbipụta] PubMed PMID: 31599456.
  • Nke 2: Kucukpolat S, Kocaaslan R, Kadihasanoglu M, Bagcioglu M, Kocan H, Sarica K. Ọgwụ Ahụike Maka Distal Ureteral Stones Ezigbo? Tamsulosin na Deflazacort: Ọnwụnwa nke ịnwere ike ibido. Aktuelle Urol. 2019 Sep 19. doi: 10.1055 / a-0770-2627. [Epub n'ihu mbipụta] PubMed PMID: 31537025.
  • 3: Tantawy MA, Alweshahy S, Elshabasy DA, Youssef NF. Mkpebi nke Oge Co-Administrated jikọrọ Deflazacort, Aprepitant na Granisetron na Dosage Forms na Spiked Human Plasma nke RP-HPLC / PAD. J Chromatogr Sci. 2019 Ọgọst 28. pic: bmz062. doi: 10.1093 / chromsci / bmz062. [Epub n'ihu mbipụta] PubMed PMID: 31504281.